BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18592007)

  • 61. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
    Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
    Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
    Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.
    Dugnani E; Sordi V; Pellegrini S; Chimienti R; Marzinotto I; Pasquale V; Liberati D; Balzano G; Doglioni C; Reni M; Gandolfi A; Falconi M; Lampasona V; Piemonti L
    Pancreatology; 2018 Dec; 18(8):945-953. PubMed ID: 30293872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
    Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
    DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.
    Brogi E; Wu T; Namiki A; Isner JM
    Circulation; 1994 Aug; 90(2):649-52. PubMed ID: 8044933
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
    Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
    Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.
    Salven P; Orpana A; Teerenhovi L; Joensuu H
    Blood; 2000 Dec; 96(12):3712-8. PubMed ID: 11090051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel methylation signature predicts inferior outcome of patients with PDAC.
    Gu M; Sun J; Zhang S; Chen J; Wang G; Ju S; Wang X
    Aging (Albany NY); 2021 Jan; 13(2):2851-2863. PubMed ID: 33550277
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics.
    Choi SH; Kim HJ; Kim KW; An S; Hong SM; Kim SC; Kim MH
    Br J Radiol; 2017 May; 90(1073):20160403. PubMed ID: 28339284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Glycolysis-Related Gene Signature Predicting Survival in Pancreatic Ductal Adenocarcinoma.
    Wang H; Xiang J; Ding L; Yang X; Wang F; Liu J; Zhao Q
    Pancreas; 2021 Mar; 50(3):e35-e37. PubMed ID: 33835985
    [No Abstract]   [Full Text] [Related]  

  • 74. VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma.
    Wróbel T; Mazur G; Dzietczenia J; Gębura K; Kuliczkowski K; Bogunia-Kubik K
    Biomed Res Int; 2013; 2013():159813. PubMed ID: 23998120
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.
    Ino Y; Yamazaki-Itoh R; Oguro S; Shimada K; Kosuge T; Zavada J; Kanai Y; Hiraoka N
    PLoS One; 2013; 8(2):e55146. PubMed ID: 23424623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. LncRNA HIF1A-AS2: a potential biomarker for early diagnosis of acute myocardial infarction and predictor of left ventricular dysfunction.
    Tayae E; Amr E; Zaki A; Elkaffash D
    BMC Cardiovasc Disord; 2023 Mar; 23(1):135. PubMed ID: 36918770
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification.
    Gotoh M; Arai E; Wakai-Ushijima S; Hiraoka N; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Kanai Y
    J Biomed Biotechnol; 2011; 2011():780836. PubMed ID: 21197409
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A systematic study of HIF1A cofactors in hypoxic cancer cells.
    Zhang Y; Wang S; Hu H; Li X
    Sci Rep; 2022 Nov; 12(1):18962. PubMed ID: 36347941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In the beginning: PDGFA and the genesis of GBM.
    Blough MD; Kumar M; Bose P; Cairncross JG
    Neuro Oncol; 2021 Apr; 23(4):697-698. PubMed ID: 33560410
    [No Abstract]   [Full Text] [Related]  

  • 80. Dual hypoxia-responsive supramolecular complex for cancer target therapy.
    Guo JS; Li JJ; Wang ZH; Liu Y; Yue YX; Li HB; Zhao XH; Sun YJ; Ding YH; Ding F; Guo DS; Wang L; Chen Y
    Nat Commun; 2023 Sep; 14(1):5634. PubMed ID: 37704601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.